You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
锦欣生殖(01951.HK)续涨逾半成首获大摩给予「增持」评级看11元
阿思达克 07-30 11:17

锦欣生殖(01951.HK)首获保荐人之一的大摩给予「增持」评级看11元,该股承昨天逆市微弹势,今早最多涨6.6%高见9.65元,现造9.51元,续升5.1%,成交已较昨天全日成交量增逾2倍至823万股。

锦欣生殖是中美领先的辅助生殖(人工授孕)服务供应商。股份於6月25日以每股8.54元在港上市,并已引入高瓴、汇桥、奥博及Cormorant为基石投资者,集资净额逾28亿元,上市联席保荐人分别为大摩和中信里昂。股份於首挂日最多涨25%至10.68元遇阻,收市仅升8.7%後,股价反覆回落,7月中旬连续两天触及上市价8.54元均获承接。

大摩指锦欣生殖业务遍及中美两国,公司於2016-2018年收入及经调整纯利年复合增长率分别为63%及64%,预期2018-2021年收入及经调整纯利年复合增长率分别为40%及56%。此外,公司具有长期运营历史和信誉良好的医生,加上优化运营模式高生产率,潜在积极中美协同效应等优势,该行首予锦欣「增持」评级,目标价11元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account